CDKN2A and type 2 diabetes mellitus: Genome-wide association studies have established that several single nucleotide polymorphisms, including loss-of function mutations in the cyclin-dependent kinase inhibitor 2A (CDKN2A) locus, affect glycemia, insulin values and T2D risk, implying a role in glucose and insulin sensitivity regulation [11,12].